tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
US Market
Advertisement

XTL Biopharmaceuticals Sponsored ADR (XTLB) Income Statement

Compare
106 Followers

XTL Biopharmaceuticals Sponsored ADR Income Statement

Last quarter (Q3 2024), XTL Biopharmaceuticals Sponsored ADR's total revenue was $162.00K, an increase of Infinity% from the same quarter last year. In Q3, XTL Biopharmaceuticals Sponsored ADR's net income was $-553.00K. See XTL Biopharmaceuticals Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 451.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 2.17M$ 765.00K$ 880.00K$ 1.03M$ 948.00K
Depreciation and Amortization
$ 199.00K$ 1.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -930.00K$ -764.00K$ -879.00K$ -1.03M$ -947.00K
Operating Income
$ -2.17M$ -765.00K$ -880.00K$ -1.03M$ -948.00K
Other Income/Expenses
$ 1.01M$ -1.02M$ -468.00K$ 1.47M$ -2.01M
Pretax Income
$ -1.16M$ -1.78M$ -1.35M$ 435.00K$ -2.95M
Net Income
$ -1.03M$ -1.78K$ -1.35M$ 435.00K$ -782.00K
Per Share Metrics
Basic EPS
$ -0.15$ 0.00$ -0.25$ 0.10$ -0.15
Diluted EPS
$ -0.15$ 0.00$ -0.25$ 0.07$ -0.15
Weighted Average Shares Outstanding
6.73M 5.45M 5.45M 5.32M 5.14M
Weighted Average Shares Outstanding (Diluted)
7.04M 5.45M 5.45M 6.16M 5.14M
Currency in USD

XTL Biopharmaceuticals Sponsored ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis